1. 3C. 3-Ketosteroid receptors in GtoPdb v.2021.3. (2021) Authors: Cain, Derek; Cidlowski, John; Edwards, Dean P.; Fuller, Peter; Grimm, Sandra L.; Hartig, Sean; Lange, Carol A.; Oakley, Robert H.; Richer, Jennifer K.; Sartorius, Carol A.; Tetel, Marc; Weigel, Nancy; Young, Morag J. Journal: IUPHAR/BPS guide to pharmacology CITE Issue: Number 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-androgen therapy in triple-negative breast cancer. (July 2016) Authors: Barton, Valerie N.; Gordon, Michael A.; Richer, Jennifer K.; Elias, Anthony Journal: Therapeutic advances in medical oncology Issue: Volume 8:Number 4(2016:Jul.) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. (15th November 2009) Authors: Cochrane, Dawn R.; Howe, Erin N.; Spoelstra, Nicole S.; Richer, Jennifer K. Other Names: Buckhaults Phillip J. Academic Editor. Journal: Journal of oncology Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The long non‐coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2‐mediated alternative splicing. Issue 2 (28th October 2018) Authors: Gordon, Michael A.; Babbs, Beatrice; Cochrane, Dawn R.; Bitler, Benjamin G.; Richer, Jennifer K. Journal: Molecular carcinogenesis Issue: Volume 58:Issue 2(2019) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗